From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct

Chronic lymphocytic leukemia (CLL) is an extremely heterogeneous disease. With the advent of oral targeted agents (Tas) the treatment of CLL has undergone a revolution, which has been accompanied by an improvement in patient’s survival and quality of life. This paradigm shift also affects the value...

Full description

Bibliographic Details
Main Authors: Isabel González-Gascón-y-Marín, Carolina Muñoz-Novas, Ana-Eugenia Rodríguez-Vicente, Miguel Quijada-Álamo, María Hernández-Sánchez, Claudia Pérez-Carretero, Victoria Ramos-Ascanio, José-Ángel Hernández-Rivas
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
chronic lymphocytic leukemia
prognosis
targeted therapy
Online Access:https://www.mdpi.com/2072-6694/13/8/1782

Internet

https://www.mdpi.com/2072-6694/13/8/1782

Similar Items